Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2014 2
2016 1
2020 1
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Amyotrophic lateral sclerosis type 9"
Page 1
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.
GBD 2017 US Neurological Disorders Collaborators; Feigin VL, Vos T, Alahdab F, Amit AML, Bärnighausen TW, Beghi E, Beheshti M, Chavan PP, Criqui MH, Desai R, Dhamminda Dharmaratne S, Dorsey ER, Wilder Eagan A, Elgendy IY, Filip I, Giampaoli S, Giussani G, Hafezi-Nejad N, Hole MK, Ikeda T, Owens Johnson C, Kalani R, Khatab K, Khubchandani J, Kim D, Koroshetz WJ, Krishnamoorthy V, Krishnamurthi RV, Liu X, Lo WD, Logroscino G, Mensah GA, Miller TR, Mohammed S, Mokdad AH, Moradi-Lakeh M, Morrison SD, Shivamurthy VKN, Naghavi M, Nichols E, Norrving B, Odell CM, Pupillo E, Radfar A, Roth GA, Shafieesabet A, Sheikh A, Sheikhbahaei S, Shin JI, Singh JA, Steiner TJ, Stovner LJ, Wallin MT, Weiss J, Wu C, Zunt JR, Adelson JD, Murray CJL. GBD 2017 US Neurological Disorders Collaborators, et al. JAMA Neurol. 2021 Feb 1;78(2):165-176. doi: 10.1001/jamaneurol.2020.4152. JAMA Neurol. 2021. PMID: 33136137 Free PMC article.
Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, traumatic brain injury, spinal cord injuries, brain and other …
Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple …
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. Byrne S, et al. J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):623-7. doi: 10.1136/jnnp.2010.224501. Epub 2010 Nov 3. J Neurol Neurosurg Psychiatry. 2011. PMID: 21047878 Review.
BACKGROUND: The population rate of familial amyotrophic lateral sclerosis (FALS) is frequently reported as 10%. ...METHOD: A Medline literature review identified all original articles reporting a rate of FALS. Studies were grouped according to the type …
BACKGROUND: The population rate of familial amyotrophic lateral sclerosis (FALS) is frequently reported as 10%. ...METH …
Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Hurwitz N, Radakovic R, Boyce E, Peryer G. Hurwitz N, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):449-458. doi: 10.1080/21678421.2021.1892765. Epub 2021 Mar 4. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33661072
Objectives: Physical pain is a known symptom in amyotrophic lateral sclerosis (ALS), but no systematically derived prevalence estimate is available. ...Heterogeneity was determined using the I(2) statistic. Where available, pain location, intensity, and ty …
Objectives: Physical pain is a known symptom in amyotrophic lateral sclerosis (ALS), but no systematically derived prev …
Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis.
Ramos-Martínez E, Ramos-Martínez I, Sánchez-Betancourt I, Ramos-Martínez JC, Peña-Corona SI, Valencia J, Saucedo R, Almeida-Aguirre EKP, Cerbón M. Ramos-Martínez E, et al. Biomolecules. 2022 Jul 31;12(8):1062. doi: 10.3390/biom12081062. Biomolecules. 2022. PMID: 36008956 Free PMC article. Review.
Patients with Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALD), and Parkinson's disease (PD) expressed higher levels of galectin-3. Patients with multiple sclerosis (MS) have higher levels of galectin-9. In conclusion, our meta-anal …
Patients with Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALD), and Parkinson's disease (PD) expressed hig …
Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.
Long C, Amoasii L, Bassel-Duby R, Olson EN. Long C, et al. JAMA Neurol. 2016 Nov 1;73(11):1349-1355. doi: 10.1001/jamaneurol.2016.3388. JAMA Neurol. 2016. PMID: 27668807 Free PMC article. Review.
EVIDENCE REVIEW: PubMed and Google Scholar were searched for articles published from June 30, 1989, through June 9, 2016, using the following keywords: genome editing, CRISPR-Cas9, neuromuscular disease, Duchenne muscular dystrophy, spinal muscular atrophy, amyotrophic …
EVIDENCE REVIEW: PubMed and Google Scholar were searched for articles published from June 30, 1989, through June 9, 2016, using the f …
The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.
Squires N, Humberstone M, Wills A, Arthur A. Squires N, et al. Dysphagia. 2014 Aug;29(4):500-8. doi: 10.1007/s00455-014-9535-8. Epub 2014 May 22. Dysphagia. 2014. PMID: 24847964 Review.
Difficulty in managing oral secretions is commonly experienced by patients with amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND) and associated bulbar weakness including dysphagia. ...Twelve studies met the inclusion criteria (9 for t …
Difficulty in managing oral secretions is commonly experienced by patients with amyotrophic lateral sclerosis (ALS)/mot …
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, van der Pol WL, Bosboom WM, Asselman FL, van den Berg LH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5. Cochrane Database Syst Rev. 2020. PMID: 32006461 Free PMC article.
This results in degeneration of anterior horn cells, which leads to progressive muscle weakness. Children with SMA type II do not develop the ability to walk without support and have a shortened life expectancy, whereas children with SMA type III develop the ability …
This results in degeneration of anterior horn cells, which leads to progressive muscle weakness. Children with SMA type II do not dev …
A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease.
Beswick E, Fawcett T, Hassan Z, Forbes D, Dakin R, Newton J, Abrahams S, Carson A, Chandran S, Perry D, Pal S. Beswick E, et al. J Neurol. 2022 Dec;269(12):6254-6268. doi: 10.1007/s00415-022-11312-7. Epub 2022 Aug 9. J Neurol. 2022. PMID: 35945397 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) is the most common subtype of motor neuron disease (MND). ...Twenty studies, involving 1275 (median 28 and ranging 6-584) pwMND, were included. Sensor type included accelerometers (n = 9), activity monitors (n …
Amyotrophic lateral sclerosis (ALS) is the most common subtype of motor neuron disease (MND). ...Twenty studies, involv …
Ethnic variation in the incidence of ALS: a systematic review.
Cronin S, Hardiman O, Traynor BJ. Cronin S, et al. Neurology. 2007 Mar 27;68(13):1002-7. doi: 10.1212/01.wnl.0000258551.96893.6f. Neurology. 2007. PMID: 17389304 Review.
To facilitate comparison, studies were grouped according to the type of data presented and examined for sources of case ascertainment and inclusion criteria. ...
To facilitate comparison, studies were grouped according to the type of data presented and examined for sources of case ascertainment …
Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review.
Alvarim LT, Nucci LP, Mamani JB, Marti LC, Aguiar MF, Silva HR, Silva GS, Nucci-da-Silva MP, DelBel EA, Gamarra LF. Alvarim LT, et al. Int J Nanomedicine. 2014 Aug 11;9:3749-70. doi: 10.2147/IJN.S65616. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25143726 Free PMC article. Review.
The increase in clinical trials assessing the efficacy of cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well known. However, the results are inconclusive as to the best cell type to be used or the be …
The increase in clinical trials assessing the efficacy of cell therapy for structural and functional regeneration of the nervous system in d …